A lot of money is sloshing around, and medical device start-ups are reaping the benefits.
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Interrupting transmission of the virus is the goal for Becton Dickinson.
In the second half of 2020 medtech began a tentative – and possibly short-lived – recovery.
It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.
A new UK plan to use antigen tests for wide-scale screening for Covid-19 may not be the easy win the government is seeking.
Though orthopaedics companies have begun to recover from the second quarter’s horrors, it is clear that the third quarter belongs to the diagnostics specialists.
Antigen tests for Covid-19 can be useful if used in the right settings, but those settings are expensive.